DDVAX
Price
$14.13
Change
+$0.06 (+0.43%)
Updated
Jul 3 closing price
Net Assets
2.24B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

DDVAX vs VIVAX

Header iconDDVAX vs VIVAX Comparison
Open Charts DDVAX vs VIVAXBanner chart's image
Macquarie Value A
Price$14.13
Change+$0.06 (+0.43%)
VolumeN/A
Net Assets2.24B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
DDVAX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DDVAX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDVAX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. DDVAX (2.25B). VIVAX pays higher dividends than DDVAX: VIVAX (2.06) vs DDVAX (1.43). DDVAX was incepted earlier than VIVAX: DDVAX (27 years) vs VIVAX (33 years). DDVAX (0.97) is less costly to investors than VIVAX (0.17). DDVAX is a more actively managed with annual turnover of: 31.00 vs. VIVAX (9.00). DDVAX has a lower initial minimum investment than VIVAX: DDVAX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. DDVAX (-16.06). VIVAX return over 5 years is better than : 80.14 vs. DDVAX (-20.72).
DDVAXVIVAXDDVAX / VIVAX
Total Expense Ratio0.970.17571%
Annual Report Gross Expense Ratio0.970.17571%
Fund Existence27 years33 years-
Gain YTD4.3366.20970%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets2.25B189B1%
Annual Yield % from dividends1.432.0670%
Returns for 1 year-16.0612.04-133%
Returns for 3 years-23.3035.16-66%
Returns for 5 years-20.7280.14-26%
Returns for 10 years-13.66115.74-12%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.